B is a diagrammatic representation of A. C is a right lateral roentgenogram taken on the same day, showing the large circular shadow (arrows) representing a loculated pleural effusion in the ...

Attempts to obliterate the pleural space go back at least as far as 1906, when Spengler 5 instilled silver nitrate in patients with spontaneous pneumothorax. Bethune 6 (1935), Medici 7 (1944) and ...

Lung Therapeutics is developing two primary drugs: LTI-01 to treat loculated pleural effusion, a serious complication of pneumonia, and LTI-03 to treat idiopathic pulmonary fibrosis.

Loculated pleural effusion (LPE) is a condition in which fluid is trapped within the pleural cavity due to fibrinous adhesions, leading to pain, shortness of breath and possibly sepsis.

AUSTIN, Texas, March 14, 2017 /PRNewswire/ -- Lung Therapeutics, Inc., a clinical stage pharmaceutical company focused on niche, orphan drug indic ...

A high-level overview of Rein Therapeutics Inc. (RNTX) stock. View (RNTX) real-time stock price, chart, news, analysis, analyst reviews and more.

The company’s lead drug, LTI-01, is in development for Loculated Pleural Effusion (LPE) and has successfully completed a clinical trial in LPE patients. The company’s ...

Rein Therapeutics is also working on other products, including LTI-01 for loculated pleural effusions and LTI-05 for cystic fibrosis. These products are noted to have the potential to contribute ...

Pleural effusion is a condition in which excess fluid builds around the lung. Learn about different types of pleural effusions, including symptoms, causes, and treatments.

LTI-01 is in development for loculated pleural effusion ("LPE"), a serious consequence of pneumonia with significant unmet medical need. La historia continúa Second Quarter 2024 Financial Results ...

Catheter is placed called Tunneled indwelling pleural catheter, so you can have pleural effusion at home. Draining the catheter 2-3 times week or as directed by the physician. Expert opinion from ...

Lung Therapeutics announced that it received Orphan Drug Designation for LTI-01, an injectable designed for the treatment of loculated pleural effusion. Lung Therapeutics, a pharmaceutical company ...